Physicians’ Perspectives on Cost, Safety, and Perceived Efficacy Determine Aminosalicylate Use in Crohn’s Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Physicians’ Perspectives on Cost, Safety, and Perceived Efficacy Determine Aminosalicylate Use in Crohn’s Disease

Published:2018-06-29 Issue:10 Volume:63 Page:2555-2563
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Ma Christopher,Ascoytia Carla,McCarrier Kelly P.,Martin Mona,Feagan Brian G.,Jairath Vipul

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/article/10.1007/s10620-018-5181-6/fulltext.html

Reference36 articles.

1. Peyrin-Biroulet L, Sandborn W, Sands BE, Reinisch W, et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target. Am J Gastroenterol. 2015;110:1324–1338.

2. Duijvestein M, Battat R, Vande Casteele N, D’Haens GR, et al. Novel therapies and treatment strategies for patients with Inflammatory bowel disease. Curr Treat Options Gastroenterol. 2018;16:129–146.

3. Schnitzler F, Fidder H, Ferrante M, Noman M, et al. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn’s disease. Inflamm Bowel Dis. 2009;15:1295–1301.

4. Baert F, Moortgat L, Van Assche G, Caenepeel P, et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn’s disease. Gastroenterology. 2010;138:463–468.

5. Rogler G. Top-down or step-up treatment in Crohn’s disease? Dig Dis. 2013;31:83–90.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the role of autophagy regulation in Crohn's disease: from genetic mechanisms to potential therapeutics;Advanced Biotechnology;2024-03-21

2. Prescriber perceptions of boxed warnings: A qualitative study;Pharmacoepidemiology and Drug Safety;2024-02-28

3. Natural Products as Dietary Agents for the Prevention and Mitigation of Oxidative Damage and Inflammation in the Intestinal Barrier;Antioxidants;2024-01-01

4. Working Together: Advances in Probiotics Combined with Mesalazine in the Treatment of Ulcerative Colitis;Advances in Clinical Medicine;2024

5. Long‐term disease course, cost and prognosis of inflammatory bowel disease: epidemiological studies of a European and a Danish inception cohort;APMIS;2023-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3